persist
infect
central
nervou
system
cn
mice
neuroadapt
jhm
strain
mous
hepat
mhv
character
ongo
demyelin
mediat
inflammatori
cell
macrophag
similar
clinic
histolog
human
demyelin
diseas
multipl
sclerosi
ms
although
extens
demyelin
occur
mice
persistentlyinfect
mhv
limit
remyelin
therefor
mhv
model
demyelin
relev
model
studi
diseas
evalu
therapeut
approach
protect
cell
oligodendrocyt
lineag
promot
remyelin
concept
highlight
etiolog
ms
remain
enigmat
virus
long
consid
potenti
trigger
agent
initi
andor
maintain
ms
symptom
understand
mechan
associ
promot
repair
within
cn
context
persist
viral
infect
critic
given
possibl
viral
eitiolog
ms
review
focus
recent
studi
use
either
mous
neural
stem
cell
nsc
human
oligodendrocyt
progenitor
cell
opc
deriv
human
embryon
stem
cell
hesc
promot
remyelin
mice
persist
infect
mhv
addit
potenti
role
chemokin
posit
migrat
transplant
cell
address
multipl
sclerosi
ms
chronic
diseas
central
nervou
system
cn
character
multifoc
region
inflamm
myelin
destruct
steinman
typic
ms
run
protract
clinic
cours
last
sever
decad
episod
exacerb
follow
variabl
period
remiss
avail
evid
indic
caus
ms
multifactori
includ
genet
background
individu
well
environment
influenc
oksenberg
et
al
poser
rain
steinman
howev
fact
discord
rate
among
monozygot
twin
report
suggest
environment
factor
microbi
infect
eg
viral
must
consid
contribut
caus
ms
eber
et
al
viral
infect
long
consid
potenti
trigger
mechan
involv
demyelin
numer
human
viral
pathogen
suggest
involv
elicit
myelinreact
lymphocyt
andor
antibodi
subsequ
infiltr
cn
damag
myelin
sheath
ascherio
munger
ascherio
munger
eber
et
al
sospedra
martin
therefor
viral
model
demyelin
clearli
relev
provid
import
insight
mechan
associ
diseas
initi
neuroinflamm
demyelin
mhv
infect
mice
result
acut
encephalomyel
follow
chronic
demyelin
similar
ms
compon
immun
system
eg
cell
macrophag
consid
import
contributor
white
matter
destruct
glass
et
al
glass
et
al
lane
et
al
liu
et
al
wu
et
al
wu
perlman
mhvinfect
mice
undergo
chronic
demyelin
exhibit
similar
clinic
histolog
diseas
profil
compar
ms
patient
herndon
et
al
lane
buchmeier
weiner
combin
fact
environment
agent
viru
consid
contribut
caus
ms
mhv
system
offer
excel
model
studi
underli
immunopatholog
mechan
may
drive
demyelin
ms
patient
well
novel
therapeut
method
promot
remyelin
import
clinic
aspect
relat
pathogenesi
human
demyelin
diseas
ms
eventu
remyelin
failur
endogen
neural
stem
cell
nsc
among
variou
experiment
approach
undertaken
promot
remyelin
cell
replac
therapi
use
mous
human
nsc
emerg
clinic
relev
increasingli
practic
method
promot
remyelin
pluchino
et
al
sher
et
al
howev
vast
major
studi
util
either
autoimmun
model
neuroinflammatorymedi
demyelin
chemicalinduc
demyelin
assess
remyelin
potenti
nsc
given
possibl
viral
infect
initi
demyelin
fact
numer
neurotrop
virus
exist
capabl
persist
within
cn
imper
evalu
remyelin
potenti
stem
cell
presenc
persist
viral
infect
correl
chronic
neuroinflamm
demyelin
intracrani
ic
infect
suscept
strain
mice
neuradapt
jhm
strain
mous
hepat
viru
jhmv
result
chronic
neuroinflamm
demyelin
within
cn
fleme
et
al
robust
inflammatori
respons
character
cell
cell
natur
killer
nk
cell
b
cell
macrophag
occur
acut
stage
infect
williamson
stohlman
williamson
et
al
studi
shown
clearanc
infecti
viru
mediat
cell
lane
et
al
marten
et
al
pearc
et
al
williamson
stohlman
cell
crucial
allow
mainten
cell
undefin
mechan
stohlman
et
al
cell
help
elimin
viru
two
distinct
mechan
part
dictat
host
cell
clearanc
infect
astrocyt
microglia
mediat
perforindepend
mechan
wherea
respons
control
infect
oligodendrocyt
lin
et
al
parra
et
al
kinet
immun
cell
infiltr
cn
respons
mhv
infect
present
figur
detail
descript
host
defens
mechan
provid
bergmann
et
al
bergmann
et
al
mhv
persist
white
matter
tract
result
chronic
demyelin
diseas
foci
demyelin
associ
area
viral
rnaantigen
last
one
year
postinfect
pi
figur
bergmann
et
al
hosk
lane
lane
buchmeier
perlman
et
al
histopathogl
analysi
mice
persist
infect
viru
reveal
numer
demyelin
axon
axon
undergo
remyelin
figur
clinic
mice
develop
loss
tail
tone
partialtocomplet
hindlimb
paralysi
result
clinic
histolog
similar
mhvinduc
demyelin
human
demyelin
diseas
multipl
sclerosi
ms
mhv
system
consid
relev
model
studi
underli
immunopatholog
mechan
contribut
immunemedi
demyelin
diseas
lane
buchmeier
mani
ms
treatment
gear
toward
reduc
neuroinflamm
ultim
goal
attenu
progress
diseas
rizvi
agiu
howev
treatment
often
address
neurodegen
phase
diseas
ie
demyelin
axon
loss
inde
remyelin
occur
spontan
adult
human
brain
evidenc
shadow
plaqu
larg
region
white
matter
undergo
remyelin
characterist
thin
myelin
sheath
halfpenni
et
al
howev
remyelin
occur
uniformli
within
lesion
across
mani
lesion
two
major
event
propos
explain
failur
remyelin
ms
difficulti
recruit
oligodendrocyt
progenitor
cell
opc
area
activ
demyelin
ii
inhibit
differenti
opc
myelincompet
oligodendrocyt
capabl
promot
remyelin
franklin
two
possibl
signal
growth
factor
cytokineschemokin
extracellular
matrix
molecul
express
neuroinflamm
thought
contribut
environ
restrict
remyelin
endogen
oligodendrocyt
stem
cell
neural
precursor
repres
attract
sourc
gener
remyelinationcompet
cell
readili
amplifi
differenti
oligodendrocyt
lineag
benhur
et
al
brustl
et
al
studi
anim
model
proven
invalu
identifi
new
method
induc
remyelin
anim
establish
demyelin
transplant
rodent
embryon
stem
cell
myelindefici
shiver
mice
result
cellular
migrat
spinal
cord
differenti
oligodendrocyt
astrocyt
myelin
axon
brustl
et
al
similarli
transplant
human
embryon
stem
cell
hesc
deriv
oligodendrocyt
progenitor
cell
myelindefici
shiver
mice
result
oligodendrocyt
differenti
remyelin
anim
model
demyelin
also
report
reduc
demyelin
follow
transplant
stem
cell
exampl
transplant
stem
cell
anim
model
acut
demyelin
result
remyelin
cao
et
al
inject
adult
neuron
precursor
mice
eae
induc
recoveri
diseas
signific
decreas
level
demyelin
pluchino
et
al
pluchino
et
al
similarli
transplant
stromal
bone
marrow
cell
demyelin
rat
spinal
cord
yield
remyelin
akiyama
et
al
transplant
human
opc
hopc
gener
hesc
spinal
cord
injur
rat
result
success
engraft
associ
cell
surviv
function
recoveri
addit
studi
also
support
neural
progenitor
cell
inher
immunogen
elicit
immun
respons
resist
destruct
allograft
rel
short
period
time
hori
et
al
modo
et
al
moreov
xenogen
transplant
hnsc
deriv
hesc
result
suppress
host
immun
respons
akesson
et
al
observ
support
addit
studi
involv
transplant
hnsc
nonhuman
primat
model
demyelin
pluchino
et
al
nonetheless
studi
support
stem
cell
deriv
immunosuppress
andor
resist
reject
follow
transplant
recogn
studi
year
ago
demonstr
transplant
allogen
neural
cell
cn
recipi
mice
result
immun
cell
infiltr
reject
mason
et
al
nichola
et
al
nichola
et
al
transplant
allogen
mix
glial
cell
cultur
result
remyelin
failur
graft
reject
one
month
rat
demyelin
lesion
induc
spinal
cord
inject
ethidium
bromid
tepavcev
blakemor
recent
eleg
track
methodolog
employ
swijnenburg
et
al
swijnenburg
et
al
demonstr
hesc
rapidli
reject
follow
inject
immunecompet
mice
inde
also
determin
hopc
deriv
hesc
transplant
mhvinfect
mice
surviv
focal
remyelin
occur
like
mediat
endogen
opc
hatch
et
al
grinnemo
et
al
grinnemo
et
al
show
hesc
express
hla
class
ii
gene
elicit
robust
infiltr
cell
macrophag
surround
hesc
soon
transplant
collect
find
emphas
potenti
clinic
hurdl
face
transplant
stem
cell
therapeut
use
even
though
stem
cell
reportedli
express
low
level
mhc
antigen
even
singl
differ
donor
esc
recipi
minor
histocompat
antigen
may
facilit
graft
reject
robertson
et
al
therefor
critic
investig
novel
strategi
induc
sustain
lifelong
toler
ensur
longterm
surviv
stem
cell
brief
review
summar
recent
studi
group
investig
therapeut
potenti
mous
human
stem
cell
promot
repair
follow
transplant
cn
mice
persist
infect
mhv
focu
point
includ
comparison
therapeut
benefit
cell
replac
therapi
use
two
distinct
stem
cell
popul
discuss
potenti
role
chemokin
contribut
posit
migrat
cell
follow
engraft
order
determin
whether
transplant
repres
viabl
strategi
treat
demyelin
necessari
better
understand
rang
environment
condit
support
transplantationmedi
remyelin
intracrani
inject
mhv
provid
environ
ongo
demyelin
pathogenesi
thu
distinct
gliotoxin
lesion
well
autoimmunemedi
demyelin
eg
eae
recent
demonstr
intraspin
transplant
mous
nsc
mice
persist
infect
jhmv
result
surviv
extens
migrat
engraft
cell
rostral
caudal
site
implant
totou
importantli
experiment
approach
transplant
syngen
nsc
deriv
mice
b
background
mhvinfect
mice
elimin
possibl
reject
transplant
result
success
engraft
major
transplant
cell
differenti
either
opc
matur
oligodendrocyt
totoiu
et
al
importantli
transplant
cell
select
accumul
within
demyelin
white
matter
tract
accompani
axon
spare
extens
remyelin
remyelin
axon
identifi
characterist
thin
myelin
sheath
figur
appear
aggreg
distribut
throughout
dorsal
ventral
later
column
amongst
demyelin
axon
contrast
nontranspl
anim
display
demyelin
axon
widespread
throughout
later
ventral
white
matter
column
remyelin
extend
cranial
caudal
implant
site
contain
remyelin
axon
regard
clinic
diseas
n
ontranspl
anim
develop
clinic
diseas
typic
character
waddl
gait
partial
hindlimb
weak
day
postinfect
progress
complet
hindlimb
paralysi
day
postinfect
persist
durat
experi
contrast
transplant
nsc
result
signific
improv
locomotor
abil
figur
given
import
inflammatori
respons
initi
maintain
diseas
mhvinfect
mice
glass
et
al
glass
et
al
lane
et
al
liu
et
al
stile
et
al
wu
et
al
wu
perlman
sought
determin
one
mechan
transplant
progenitor
cell
promot
remyelin
modifi
sever
inflamm
address
question
first
evalu
leukocyt
infiltr
cn
flow
cytometri
day
post
transplant
nsc
vehicl
control
overal
frequenc
infiltr
cell
cell
macrophag
high
alter
mice
receiv
progenitor
cell
compar
control
mice
frequenc
number
virusspecif
cell
affect
transplant
mice
hardison
et
al
analysi
proinflammatori
chemokin
cytokin
gene
express
reveal
chang
abund
specif
mrna
transcript
transplant
versu
nontranspl
mice
find
mark
contrast
earlier
studi
pluchino
colleagu
pluchino
et
al
demonstr
neuroprotect
effect
nsc
mediat
predominantli
immunomodulatori
effect
use
mous
model
eae
longterm
surviv
undifferenti
nsc
persist
within
perivascular
area
wherebi
particip
protect
promot
apoptosi
infiltr
inflammatori
cell
pluchino
et
al
similarli
einstein
et
al
einstein
et
al
also
observ
mute
infiltr
cell
cn
follow
nsc
transplant
cn
mice
eae
coincid
increas
regulatori
cell
dampen
neuroinflamm
associ
diminish
tissu
injuri
accompani
improv
clinic
outcom
einstein
et
al
mechan
associ
nscmediat
immun
regul
indic
upon
subcutan
inject
cell
mice
establish
eae
nsc
abl
preferenti
accumul
within
drain
lymph
node
pluchino
et
al
resid
defin
anatom
locat
nsc
found
dampen
activ
myeloid
dendrit
cell
result
restrain
expans
antigenspecif
encephalitongen
cell
differ
therapeut
effect
nsc
observ
mhv
model
diseas
compar
observ
eae
model
may
explain
sever
potenti
import
reason
persist
viral
infect
cn
may
creat
vastli
differ
environ
within
cn
compar
diseas
induc
inject
encephalitogen
myelin
peptid
combin
adjuv
influenc
biolog
transplant
nsc
asofyet
undefin
mechan
site
nsc
implant
well
time
inject
may
critic
regard
cell
function
inject
nsc
spinal
cord
mice
persist
infect
viru
well
neuroinflamm
demyelin
evid
moreov
observ
migrat
engraft
cell
peripher
organ
eg
lymph
node
spleen
may
immunodulatori
effect
contrast
introduct
nsc
via
intraven
intraventricular
subcutan
inject
earli
follow
immun
myelin
epitop
clearli
result
differenti
outcom
within
context
cell
accumul
function
therapeut
outcom
factor
must
consid
evalu
translat
benefit
cell
replac
therapi
treat
chronic
inflammatori
neurolog
diseas
ms
laboratori
interest
determin
whether
transplant
clinic
applic
hescderiv
opc
promot
remyelin
use
mhvmodel
demyelin
abil
clinic
applic
cell
facilit
remyelin
model
ms
would
essenti
step
toward
develop
novel
therapi
perhap
allur
sourc
opc
hesc
easili
amplifi
appear
harbor
limitless
potenti
propag
readili
differenti
moreov
embryon
deriv
may
profici
migrat
myelin
compar
adult
counterpart
recent
suggest
other
blakemor
irvin
sim
et
al
wolswijk
nobl
import
note
howev
broad
plastic
hesc
undifferenti
cell
amariglio
et
al
may
also
detriment
spuriou
propag
unwant
potenti
harm
cell
type
could
result
tumor
heterolog
tissu
format
within
recipi
therefor
obtain
highpur
popul
predifferenti
opc
essenti
safe
effect
clinic
use
inde
hesc
differenti
highpur
opc
abl
integr
matur
form
compact
myelin
dysmyelin
shiver
mice
spinal
cord
injur
rat
howev
recent
determin
transplant
highpur
opc
mhvinfect
mice
establish
demyelin
result
either
improv
clinic
recoveri
promot
extens
remyelin
hatch
et
al
importantli
implant
cell
fail
surviv
longer
week
posttransplant
spite
administr
immunosuppress
dampen
cell
function
transplant
cell
migrat
site
inject
focal
remyelin
observ
contrast
human
nsc
recent
shown
surviv
exert
neuroprotect
effect
mous
nonhuman
primat
model
eae
aharonowiz
et
al
pluchino
et
al
similar
result
observ
mous
nsc
therapeut
effect
human
nsc
associ
immun
regul
collect
find
emphas
complex
cell
replac
therapi
regard
understand
local
environ
allow
transplant
cell
surviv
moreov
studi
highlight
import
model
system
util
matur
state
transplant
cell
well
rout
inject
regard
understand
natur
clinic
relev
approach
treat
human
neurolog
diseas
regard
differ
surviv
repair
follow
transplant
hescderiv
opc
mhvinfect
mice
studi
discuss
well
work
mous
nscmediat
repair
mhvinfect
mice
sever
possibl
explan
first
unlik
differenti
opc
share
capac
migrat
nsc
either
mous
human
restrict
abil
transplant
cell
extens
remyelin
axon
follow
inject
mhvinfect
mice
secondli
never
observ
engraft
cell
mous
human
migrat
secondari
lymphat
tissu
cervic
lymph
node
follow
transplant
mhvinfect
mice
limit
possibl
immun
modul
find
emphas
import
rout
deliveri
eg
iv
deliveri
versu
inject
spinal
cord
effector
function
transplant
cell
popul
highlight
matur
stage
cell
opc
versu
nsc
may
also
critic
traffick
lymph
node
also
affect
cell
respons
directli
within
cn
although
mechan
transplant
nsc
protect
tissu
injuri
promot
clinic
recoveri
may
differ
depend
upon
model
system
employ
clear
surviv
engraft
cell
mobil
abl
specif
accumul
target
tissu
posit
migrat
defin
anatom
locat
numer
studi
demonstr
nsc
express
chemokin
receptor
support
import
role
allow
cell
prolifer
andor
migrat
upon
inject
beech
et
al
dziembowska
et
al
gordon
et
al
guan
et
al
imitola
et
al
itoh
et
al
tran
et
al
van
der
meulen
et
al
determin
glialenrich
cultur
deriv
mous
nsc
secret
chemokin
respons
cytokin
treatment
whitman
et
al
addit
found
nsc
well
differenti
oligodendrocyt
progenitor
cell
opc
deriv
nsc
express
array
chemokin
receptor
includ
unpublish
observ
figur
moreov
treatment
hopc
either
alon
combin
also
result
increas
express
mrna
transcript
specif
defin
chemokin
includ
well
chemokin
receptor
transplant
cell
also
found
express
chemokin
receptor
immunostain
reveal
engraft
mous
nsc
express
cell
enrich
within
white
matter
tract
undergo
demyelin
figur
ligand
also
strongli
express
within
demyelin
white
matter
tract
suggest
implant
nsc
preferenti
migrat
accumul
within
area
demyelin
respond
unpublish
observ
current
pursu
function
relev
chemokin
receptor
express
transplant
nsc
express
hescderiv
opc
week
posttransplant
yet
believ
chemokin
receptor
other
function
transplant
cell
display
minim
migrat
site
inject
hatch
et
al
unpublish
observ
also
bear
mention
observ
dramat
increas
transcript
encod
member
ccr
bind
chemokin
receptor
cultur
nsc
treat
cytokin
elimin
potenti
import
role
cc
chemokin
particip
transplant
nscmediat
repair
mhv
model
system
interpret
find
cxc
bind
receptor
may
import
mediat
traffick
well
matur
follow
engraft
standard
treatment
immunomodul
andor
immunosuppress
yield
rang
degre
success
patient
immunemedi
demyelin
diseas
rizvi
agiu
injuri
sayer
et
al
clear
complex
natur
demyelin
warrant
novel
approach
focu
limit
inflamm
neurodegener
also
promot
repair
potenti
novel
therapi
may
relat
discov
specif
target
exploit
dual
natur
neuroinflamm
order
suppress
degen
compon
simultan
enhanc
neuroprotect
remyelin
endogen
oligodendrocyt
ii
provid
support
remyelinationcompet
endogen
opc
oligodendrocyt
iii
implant
myelinogen
cell
site
neuroinflamm
directli
capabl
induc
remyelin
damag
axon
individu
applic
method
met
success
murin
model
demyelin
import
rememb
success
system
may
necessarili
translat
human
diseas
moreov
understand
transplant
cell
undergo
migrat
order
accumul
within
area
patholog
also
critic
consid
potenti
enhanc
traffick
regard
evalu
function
contribut
chemokin
receptor
express
nsc
allow
engraft
cell
posit
migrat
repres
import
hurdl
understand
cell
replac
therapi
treat
chronic
neurolog
diseas
although
viral
titer
clear
detect
level
via
plaqu
assay
day
viral
rna
antigen
remain
detect
year
postinfect
pi
anim
reduc
viral
titer
within
cn
demyelin
lesion
clinic
diseas
initi
also
last
year
pi
cell
macrophag
contribut
demyelin
mice
persist
infect
mhv
epitop
spread
ie
gener
autoreact
cell
thought
contribut
white
matter
damag
mhv
model
system
shade
area
b
repres
limit
detect
cn
viru
determin
plaqu
assay
averag
clinic
score
mice
receiv
intraspin
inject
neural
stem
cell
cell
vehicl
control
hbss
cell
transplant
mice
establish
demyelin
day
postinfect
neuroadapt
strain
jhmv
score
base
four
point
scale
abnorm
limp
tail
waddl
gait
partial
hind
limb
weak
hind
limb
paralysi
dead
p
nsc
isol
striatal
tissu
postnat
day
mice
differenti
high
puriti
cultur
opc
immunostain
use
specif
antibodi
direct
detect
secondari
fluoresc
conjug
antibodi
analyz
use
confoc
microscopi
figur
merg
zstack
origin
project
thick
plane
stain
shown
red
green
respect
blue
repres
nuclear
dapi
stain
scale
bar
